Structure Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Structure Therapeutics Inc.
Former names: ShouTi Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Cayman Islands
Headquarters city: South SAN Francisco
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: GPCR
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001888886
EIN: 98-1480821

Board of directors

Follow this board

Angus C. Russell · Director
Since 2024
Daniel G. Welch · Director
Since 2023
Eric Dobmeier · Director
Since 2023
Joanne Waldstreicher · Director
Since 2023
Ramy Farid · Director
Since 2023
Raymond C. Stevens · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Sharon Tetlow · Director
Since 2023
Ted W. Love · Director Overboarded
Since 2023

Chief executives

Raymond C. Stevens · Chief Executive Officer

Since February 2023

Director election results

Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 15 other boards. 14 are in the same sector.

Shared director Other board Same sector

Atara Biotherapeutics Inc. Same sector
via Eric Dobmeier
Becton Dickinson and Company Same sector
via Joanne Waldstreicher
Danaher Corporation
via Raymond C. Stevens
Gilead Sciences Inc. Same sector
via Ted W. Love
Jade Biosciences Inc. Same sector
via Eric Dobmeier
Janux Therapeutics Inc. Same sector
via Eric Dobmeier
Jazz Pharmaceuticals plc Same sector
via Ted W. Love
Lineage Cell Therapeutics Inc. Same sector
via Angus C. Russell
Lisata Therapeutics Inc. Same sector
via Ted W. Love
Nuvation Bio Inc. Same sector
via Daniel G. Welch
Prothena Corporation plc Same sector
via Daniel G. Welch
Royalty Pharma plc Same sector
via Ted W. Love
Schrodinger Inc. Same sector
via Ramy Farid
Ultragenyx Pharmaceutical Inc. Same sector
via Daniel G. Welch
Vir Biotechnology Inc. Same sector
via Ramy Farid

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 21, 2026	Coll Crespo Blas Officer (CHIEF MEDICAL OFFICER)	Derivative conversion	−12,024	—	—
Sep 18, 2026	Coll Crespo Blas Officer (CHIEF MEDICAL OFFICER)	Shares withheld for tax	−10,626	$11.67	$124,005
Sep 1, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Option exercise	+17,817	$0.34	$6,058
Sep 1, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Derivative conversion	−17,817	—	—
Aug 18, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Option exercise	+11,817	$0.34	$4,018
Aug 18, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Derivative conversion	−11,817	—	—
Aug 6, 2026	Berrios John Joseph Officer (Chief Commercial Officer)	Grant or award	+140,766	—	—
Aug 4, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Option exercise	+11,817	$0.34	$4,018
Aug 4, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Derivative conversion	−11,817	—	—
Jul 14, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Option exercise	+23,634	$0.34	$8,036
Jul 14, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Derivative conversion	−23,634	—	—
Jun 25, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Option exercise	+23,634	$0.34	$8,036
Jun 25, 2026	Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER)	Derivative conversion	−23,634	—	—
Apr 15, 2026	Lang Matthew Officer (COO & GC)	Grant or award	+184,614	—	—
Mar 19, 2026	Hall Ashley Officer (Chief Development Officer)	Grant or award	+47,706	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Structure Therapeutics Inc.

Who is the CEO of Structure Therapeutics Inc.?

Raymond C. Stevens has been Structure Therapeutics Inc.'s Chief Executive Officer since February 2023.

How many directors are on Structure Therapeutics Inc.'s board?

Structure Therapeutics Inc.'s board has 8 directors: Angus C. Russell, Daniel G. Welch, Eric Dobmeier, Joanne Waldstreicher, Ramy Farid, Raymond C. Stevens, Sharon Tetlow and Ted W. Love.

How is Structure Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="structure-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.